Skip to content
Baret News – Lifestyle
Author:
Galecto, Inc.
Galecto Announces Name Change to Damora Therapeutics with Mission to Fundamentally Redefine Care for Patients with Blood Disorders
March 9, 2026
Galecto Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 4, 2026